Eyebright Medical Technology (Beijing) Co., Ltd. (SHA:688050)
74.41
+1.13 (1.54%)
Sep 30, 2025, 3:00 PM CST
SHA:688050 Revenue
Eyebright Medical Technology (Beijing) had revenue of 429.51M CNY in the quarter ending June 30, 2025, with 14.44% growth. This brings the company's revenue in the last twelve months to 1.51B, up 22.84% year-over-year. In the year 2024, Eyebright Medical Technology (Beijing) had annual revenue of 1.41B with 48.24% growth.
Revenue (ttm)
1.51B
Revenue Growth
+22.84%
P/S Ratio
9.52
Revenue / Employee
614.22K
Employees
2,294
Market Cap
14.39B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.41B | 458.85M | 48.24% |
Dec 31, 2023 | 951.18M | 371.68M | 64.14% |
Dec 31, 2022 | 579.50M | 146.43M | 33.81% |
Dec 31, 2021 | 433.07M | 160.02M | 58.61% |
Dec 31, 2020 | 273.05M | 77.85M | 39.88% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
WuXi AppTec | 41.90B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Sichuan Biokin Pharmaceutical | 441.19M |
Shanghai United Imaging Healthcare | 10.98B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
Aier Eye Hospital Group | 21.94B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |